Log In
Print
BCIQ
Print
Print this Print this
 

Pixuvri, pixantrone

Also known as: formerly BBR 2778

  Manage Alerts
Collapse Summary General Information
Company CTI BioPharma Corp.
DescriptionAza-anthracenedione DNA intercalating agent that inhibits topoisomerase II (TOP2)
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor; DNA intercalating agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$133.0M

$18.0M

$115.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today